Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Vitro Diagnostics (VODG) had Revenue of $0.53M for the most recently reported fiscal quarter, ending 2026-01-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-01-31

Income Statement Financials
Revenue	$0.53M
Net Income	$-1.15M
Cost of Goods Sold	$0.12M
Gross Profit	$0.41M
Operating Expenses	$1.72M
Operating Income	$-1.19M
Non-Operating Income/Expense	$0.09M
Pre-Tax Income	$-1.11M
Normalized Pre-Tax Income	$-1.11M
Income after Taxes	$-1.11M
Income from Continuous Operations	$-1.11M
Consolidated Net Income/Loss	$-1.11M
Normalized Income after Taxes	$-1.11M
EBIT	$-1.19M
EBITDA	$-0.70M
Weighted-Average Shares Outstanding (Basic)	4.48M
Weighted-Average Shares Outstanding (Diluted)	4.48M
Earnings per Share (EPS) (Basic)	$-0.26
Earnings per Share (EPS) (Diluted)	$-0.26
Balance Sheet Financials
Current Assets	$0.87M
Property, Plant, and Equipment	$0.03M
Long-Term Assets	$4.02M
Total Assets	$4.89M
Current Liabilities	$5.42M
Long-Term Debt	$9.43M
Long-Term Liabilities	$15.61M
Total Liabilities	$21.04M
Common Equity	$-16.15M
Tangible Shareholders Equity	$-19.80M
Shareholders Equity	$-16.15M
Common Shares Outstanding	4.52M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-1.11M
Cash Flow from Investing Activities	$-0.00M
Cash Flow from Financial Activities	$1.00M
Beginning Cash	$0.60M
End Cash	$0.49M
Increase/Decrease in Cash	$-0.11M
Stock-Based Compensation	$0.29M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.16
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-1.40
Debt to Equity Ratio	-0.62
Gross Margin	77.81%
Operating Margin	-225.14%
EBIT Margin	-225.14%
EBITDA Margin	--
Pre-Tax Profit Margin	-209.09%
Profit Margin	-217.30%
Free Cash Flow	$-1.11M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.11
Inventory Turnover	0.92
Receiveable Turnover	2.55
Days Sales in Receivables	35.34
Return on Equity	6.85%
Return on Tangible Equity	5.59%
Return on Assets	-22.65%
Return on Investments	16.48%
Book Value Per Share	$-3.57
Free Cash Flow per Share	$-0.25
Operating Cash Flow per Share	$-0.25

Data from Zacks Investment Research, Inc.